TY - JOUR
T1 - Determinants of Non-infectious Scleritis Complications and Their Impact on Visual Outcome
T2 - Results from the International AIDA Network Scleritis Registry
AU - Sota, Jurgen
AU - Hinojosa-Azaola, Andrea
AU - de-la-Torre, Alejandra
AU - Giardini, Henrique Ayres Mayrink
AU - Guerriero, Silvana
AU - Kawakami-Campos, Perla Ayumi
AU - Martín-Nares, Eduardo
AU - Guaracha-Basañez, Guillermo Arturo
AU - Ragab, Gaafar
AU - Chimenti, Maria Sole
AU - Lopalco, Giuseppe
AU - Hissaria, Pravin
AU - Cattalini, Marco
AU - Ruscitti, Piero
AU - Tharwat, Samar
AU - Ruiz-Irastorza, Guillermo
AU - García-Madero, Juan José
AU - Tierradentro-Alape, Rafael
AU - Hegazy, Mohamed Tharwat
AU - Afifi, Kerolos
AU - Emmi, Giacomo
AU - Parronchi, Paola
AU - Paroli, Maria Pia
AU - Hernández-Rodríguez, José
AU - Sainz-de-la-Maza, Maite
AU - Caggiano, Valeria
AU - Sbalchiero, Jessica
AU - Bugatti, Serena
AU - Gaggiano, Carla
AU - Breda, Luciana
AU - Dammacco, Rosanna
AU - Monosi, Benedetta
AU - Capodiferro, Marco
AU - Beecher, Marc
AU - Olivieri, Alma Nunzia
AU - Batu, Ezgi Deniz
AU - Ozen, Seza
AU - Frediani, Bruno
AU - Thabet, Maissa
AU - Balistreri, Alberto
AU - Gupta, Vishali
AU - Fonollosa, Alex
AU - Vitale, Antonio
AU - Cantarini, Luca
AU - Fabiani, Claudia
N1 - Publisher Copyright:
© The Author(s) 2026.
PY - 2026
Y1 - 2026
N2 - Introduction: Scleritis is a rare and severe ocular inflammatory disease that is often associated with potentially sight-threatening ocular complications. The aim of the present study was to characterize ocular complications in non-infectious scleritis and identify predictive variables for their development. Methods: Data for this registry-based study were extracted from the AutoInflammatory Disease Alliance Network for Scleritis Registry. Univariate analysis was performed to examine potential associations of demographic and clinical variables with the development of ocular complications. Uveitis and peripheral ulcerative keratitis were considered to be extensions of the inflammatory process and not to be true structural complications. Predictive factors of ocular complications were assessed using regression analysis. The impact of ocular complications on visual acuity—measured by best-corrected visual acuity (BCVA)—was also analyzed. Results: A total of 154 patients (218 eyes) with non-infectious scleritis were enrolled. In 58 of these patients (87 eyes), 102 ocular complications were recorded, with cataract, scleral and corneal thinning, and glaucoma and/or increased ocular pressure being the most frequently recorded complications. Ocular complications were found to be significantly more frequent among patients affected by granulomatosis with polyangiitis (GPA) (p < 0.0001) and concomitant uveitis (p = 0.023). The mean severity score was significantly higher among eyes experiencing ocular complications (p < 0.0001). Regression analysis identified three variables capable of predicting the development of ocular complications: a diagnosis of GPA [odds ratio (OR) 7.747, p < 0.0001]; the presence of concomitant uveitis (OR 3.648, p = 0.019); and a high severity score (OR 1.138, p = 0.044). Mean (± standard deviation) BCVA converted to logMAR was found to be significantly higher among eyes without ocular complications (0.12 ± 0.24 vs 0.27 ± 0.49; p = 0.005). Conclusion: Scleritis was accompanied by irreversible ocular complications in a considerable proportion of the patients enrolled in this study. Patients with a diagnosis of GPA, concomitant uveitis, and a higher severity score are more likely to develop ocular complications, and thus warrant a tighter follow-up schedule and early treatment in order to minimize the risk of poor visual prognosis.
AB - Introduction: Scleritis is a rare and severe ocular inflammatory disease that is often associated with potentially sight-threatening ocular complications. The aim of the present study was to characterize ocular complications in non-infectious scleritis and identify predictive variables for their development. Methods: Data for this registry-based study were extracted from the AutoInflammatory Disease Alliance Network for Scleritis Registry. Univariate analysis was performed to examine potential associations of demographic and clinical variables with the development of ocular complications. Uveitis and peripheral ulcerative keratitis were considered to be extensions of the inflammatory process and not to be true structural complications. Predictive factors of ocular complications were assessed using regression analysis. The impact of ocular complications on visual acuity—measured by best-corrected visual acuity (BCVA)—was also analyzed. Results: A total of 154 patients (218 eyes) with non-infectious scleritis were enrolled. In 58 of these patients (87 eyes), 102 ocular complications were recorded, with cataract, scleral and corneal thinning, and glaucoma and/or increased ocular pressure being the most frequently recorded complications. Ocular complications were found to be significantly more frequent among patients affected by granulomatosis with polyangiitis (GPA) (p < 0.0001) and concomitant uveitis (p = 0.023). The mean severity score was significantly higher among eyes experiencing ocular complications (p < 0.0001). Regression analysis identified three variables capable of predicting the development of ocular complications: a diagnosis of GPA [odds ratio (OR) 7.747, p < 0.0001]; the presence of concomitant uveitis (OR 3.648, p = 0.019); and a high severity score (OR 1.138, p = 0.044). Mean (± standard deviation) BCVA converted to logMAR was found to be significantly higher among eyes without ocular complications (0.12 ± 0.24 vs 0.27 ± 0.49; p = 0.005). Conclusion: Scleritis was accompanied by irreversible ocular complications in a considerable proportion of the patients enrolled in this study. Patients with a diagnosis of GPA, concomitant uveitis, and a higher severity score are more likely to develop ocular complications, and thus warrant a tighter follow-up schedule and early treatment in order to minimize the risk of poor visual prognosis.
UR - https://www.scopus.com/pages/publications/105038791931
UR - https://www.scopus.com/pages/publications/105038791931#tab=citedBy
U2 - 10.1007/s40123-026-01390-5
DO - 10.1007/s40123-026-01390-5
M3 - Research Article
C2 - 42105127
AN - SCOPUS:105038791931
SN - 2193-8245
JO - Ophthalmology and Therapy
JF - Ophthalmology and Therapy
ER -